CBD of Denver Signs Definitive Share Exchange Agreement with BioCannabis M. IKE
CBDD is trading near its 52-week low of $0 (0.0% above the low) on light trading volume (0.1× avg).
Summary
CBD of Denver has signed a definitive Share Exchange Agreement to acquire BioCannabis M. IKE, a Greece-based health and wellness company with cultivation, processing, and extraction facilities. This follows the due diligence phase announced in June and moves the strategic merger toward completion. The transaction will be paid in CBDD shares, subject to closing conditions and regulatory approvals. Management views this as a key step in its transformation into the health and wellness sector. Further details on the combined company's structure and operations are expected after closing.
At the time of this announcement, CBDD was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $10.7K. The 52-week trading range was $0.00 to $0.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: TMX Newsfile.